Switch theme
Sign up to access all valuation multiples
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
2011
1.5K+
LTM Revenue $318M
LTM EBITDA $31.9M
$324M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Health Catalyst has a last 12-month revenue (LTM) of $318M and a last 12-month EBITDA of $31.9M.
In the most recent fiscal year, Health Catalyst achieved revenue of $307M and an EBITDA of -$10.7M.
Health Catalyst expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Health Catalyst valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $318M | XXX | $307M | XXX | XXX | XXX |
| Gross Profit | $151M | XXX | $141M | XXX | XXX | XXX |
| Gross Margin | 48% | XXX | 46% | XXX | XXX | XXX |
| EBITDA | $31.9M | XXX | -$10.7M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | -3% | XXX | XXX | XXX |
| EBIT | -$60.8M | XXX | -$69.8M | XXX | XXX | XXX |
| EBIT Margin | -19% | XXX | -23% | XXX | XXX | XXX |
| Net Profit | $16.7M | XXX | -$69.5M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | -23% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $133M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Health Catalyst's stock price is $4.
Health Catalyst has current market cap of $264M, and EV of $324M.
See Health Catalyst trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $324M | $264M | XXX | XXX | XXX | XXX | $0.26 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Health Catalyst has market cap of $264M and EV of $324M.
Health Catalyst's trades at 1.1x EV/Revenue multiple, and -30.4x EV/EBITDA.
Equity research analysts estimate Health Catalyst's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Health Catalyst has a P/E ratio of 15.8x.
See valuation multiples for Health Catalyst and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $264M | XXX | $264M | XXX | XXX | XXX |
| EV (current) | $324M | XXX | $324M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 10.2x | XXX | -30.4x | XXX | XXX | XXX |
| EV/EBIT | -5.3x | XXX | -4.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 15.8x | XXX | -3.8x | XXX | XXX | XXX |
| EV/FCF | -13.8x | XXX | -176.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHealth Catalyst's last 12 month revenue growth is 9%
Health Catalyst's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Health Catalyst's rule of 40 is -14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Health Catalyst's rule of X is 33% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Health Catalyst and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | -3% | XXX | XXX | XXX |
| EBITDA Growth | 40% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -14% | XXX | 6% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 33% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 19% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 69% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
| Cogstate | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
| Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Health Catalyst acquired XXX companies to date.
Last acquisition by Health Catalyst was XXXXXXXX, XXXXX XXXXX XXXXXX . Health Catalyst acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Health Catalyst founded? | Health Catalyst was founded in 2011. |
| Where is Health Catalyst headquartered? | Health Catalyst is headquartered in United States of America. |
| How many employees does Health Catalyst have? | As of today, Health Catalyst has 1.5K+ employees. |
| Who is the CEO of Health Catalyst? | Health Catalyst's CEO is Mr. Daniel Burton. |
| Is Health Catalyst publicy listed? | Yes, Health Catalyst is a public company listed on NAS. |
| What is the stock symbol of Health Catalyst? | Health Catalyst trades under HCAT ticker. |
| When did Health Catalyst go public? | Health Catalyst went public in 2019. |
| Who are competitors of Health Catalyst? | Similar companies to Health Catalyst include e.g. Beamtree, Cogstate, Echo IQ, Impedimed. |
| What is the current market cap of Health Catalyst? | Health Catalyst's current market cap is $264M |
| What is the current revenue of Health Catalyst? | Health Catalyst's last 12 months revenue is $318M. |
| What is the current revenue growth of Health Catalyst? | Health Catalyst revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Health Catalyst? | Current revenue multiple of Health Catalyst is 1.0x. |
| Is Health Catalyst profitable? | Yes, Health Catalyst is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Health Catalyst? | Health Catalyst's last 12 months EBITDA is $31.9M. |
| What is Health Catalyst's EBITDA margin? | Health Catalyst's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Health Catalyst? | Current EBITDA multiple of Health Catalyst is 10.2x. |
| What is the current FCF of Health Catalyst? | Health Catalyst's last 12 months FCF is -$23.4M. |
| What is Health Catalyst's FCF margin? | Health Catalyst's last 12 months FCF margin is -7%. |
| What is the current EV/FCF multiple of Health Catalyst? | Current FCF multiple of Health Catalyst is -13.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
